Serial #86898181
LIVE

Serial Number

86898181

Owner

Animal Cell Therapies, Inc.

Attorney

Jeffrey Sheriff

First Use Date

Feb 17, 2013

Filing Date

Feb 4, 2016

Add to watchlist:

No watchlists yet
View on USPTO

Serial #86898181 Trademark

Serial Number: 86898181 • Registration: 5224118

Serial #86898181 is a trademark filed by Animal Cell Therapies, Inc. on February 4, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Animal Cell Therapies, Inc. (17 trademarks)

836 Prospect Street, Suite 2B
La Jolla, CA 92037

Entity Type: 03

Trademark Details

Filing Date

February 4, 2016

Registration Date

June 13, 2017

First Use Anywhere

February 17, 2013

First Use in Commerce

February 17, 2013

Published for Opposition

August 16, 2016

Goods & Services

Cells for medical or clinical use; Stem cells for medical or veterinary purposes; Pharmaceutical preparations for use in tissue engineered and cell based veterinary and medical therapies for use in the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune- mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations manufactured or modified by genetic engineering in the form of stem cells for veterinary and medical purposes; Pharmaceutical and veterinary preparations, namely, gene therapy products in the form of stem cells for therapeutic medical use; Biochemical preparations namely, preparations for use in gene therapy for the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Orthobiologic preparations, namely, biologic preparations in the nature of stem cells to achieve symptomatic relief and cures from various orthopedic diseases

Medical and scientific research services in the field of animal stem cells for research, diagnostic, and clinical use; biopharmaceutical development, research and evaluation services of stem cell-based therapeutics for the treatment of disease, injuries and disorders; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics

Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; cells for scientific, laboratory or medical research; stem cells for research or scientific research purposes

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 13, 2026 REM2
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 30, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 30, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 30, 2024 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 11, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 10, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 9, 2023 APRE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 22, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 22, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 22, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 22, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 22, 2023 COAR
TEAS SECTION 8 & 15 RECEIVED
May 12, 2023 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 5, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 5, 2022 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 13, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 13, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 9, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 8, 2017 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2017 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Apr 21, 2017 SUPC
SOU EXTENSION 1 GRANTED
Apr 21, 2017 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 20, 2017 AITU
USE AMENDMENT FILED
Apr 11, 2017 IUAF
SOU EXTENSION 1 FILED
Apr 11, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 11, 2017 EEXT
TEAS STATEMENT OF USE RECEIVED
Apr 11, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 11, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2016 NPUB
PUBLISHED FOR OPPOSITION
Aug 16, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 27, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 6, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 6, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 6, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 6, 2016 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2016 CNRT
ASSIGNED TO EXAMINER
May 19, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 11, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2016 NWOS
NEW APPLICATION ENTERED
Feb 8, 2016 NWAP